Marko T Markov

Title: Marko T Markov: Innovator in Ophthalmic Solutions

Introduction

Marko T Markov is a notable inventor based in Sofia, Bulgaria. He has made significant contributions to the field of ophthalmology, particularly in the treatment of glaucoma. With a total of 2 patents, his work reflects a commitment to advancing medical solutions for eye health.

Latest Patents

Markov's latest patents include a composition and method for treating glaucoma. This antiglaucoma composition features an active component, a s-/-/-2,3 dihydroxy-9,10,11-trimethoxy-5,8,13,13a-tetrahydro-6H-dibenzo (a,f) quinolizine hydrochloride. The formulation is designed for use as an ophthalmic solution, administered in therapeutic doses of 2 to 3 drops two to four times daily to warm-blooded animals suffering from glaucoma. Another patent involves compounds of the formula (I), which have the ability to inhibit adenylate cyclase, showcasing his innovative approach to pharmaceutical development.

Career Highlights

Throughout his career, Marko has worked with reputable companies such as TPO Pharmachim and Pharmachim. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Marko has collaborated with notable colleagues, including Chavdar B Ivanov and Nikolina D Berova. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Marko T Markov stands out as an influential inventor in the field of ophthalmology, with a focus on innovative treatments for glaucoma. His contributions through patents and collaborations highlight his dedication to improving eye health solutions.